Oculis Holding AG OCS
NASDAQ OCS
$8.73 -0.03 (-0.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Other Accumulated Expenses (2023 - 2025)

Updated

Oculis Holding AG (OCS) reported Other Accumulated Expenses of $2.29 million for Q4 2025, compared with $13,698 a year earlier.

Analysis

Oculis Holding AG (OCS) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

  • By year, Other Accumulated Expenses came in at $13,640 in FY2024 (+72.8%) and $7,891 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Oculis Holding AG 456.08 Mn 456.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.29 Mn
Dec 31, 2024 13,698.26
Dec 31, 2023 7,891.48
API Access

Oculis Holding AG Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OCS&period=max&api_key=YOUR_API_KEY